Bone grafts and their substitutes

Bone and Joint Journal

Volumn 98B, Issue 1, 2016, Pages 6-9

  Fillingham, Y ^a   Jacobs, J ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCERAMICS; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; CALCIUM SULFATE; HYDROXYAPATITE; OSTEOGENIC PROTEIN 1; PROCOLLAGEN C PROTEINASE; ROSEOLIC ACID; BONE PROSTHESIS;

ARTICLE; AUTOGRAFT; BONE ALLOGRAFT; BONE CONDUCTION; BONE DEVELOPMENT; BONE GRAFT; BONE MASS; BONE REMODELING; BONE TRANSPLANTATION; MESENCHYMAL STEM CELL; OSTEOBLAST; OSTEOCYTE; OSTEOINDUCTION; OSTEOSYNTHESIS; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; SYSTEMATIC REVIEW (TOPIC); TISSUE ENGINEERING; BONE PROSTHESIS; HUMAN; THERAPEUTIC USE;

BONE SUBSTITUTES; BONE TRANSPLANTATION; HUMANS;

EID: 84955306388     PISSN: 20494394     EISSN: 20494408     Source Type: Journal    
DOI: 10.1302/0301-620x.98b.36350     Document Type: Article

References (35)

1. Compton JT, Lee FY. A review of osteocyte function and the emerging importance of sclerostin. J Bone Joint Surg [Am] 2014;96-A:1659-1668.
2. Knothe Tate ML, Adamson JR, Tami AE, Bauer TW. The osteocyte. Int J Biochem Cell Biol 2004;36:1-8.
3. Ulstrup AK. Biomechanical concepts of fracture healing in weight-bearing long bones. Acta Orthop Belg 2008;74:291-302.
4. Atkins GJ, Rowe PS, Lim HP, et al. Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism. J Bone Miner Res 2011;26:1425-1436.
5. Genetos DC, Yellowley CE, Loots GG. Prostaglandin E2 signals through PTGER2 to regulate sclerostin expression. PLoS One 2011;6:17772.
6. Tian X, Jee WS, Li X, Paszty C, Ke HZ. Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobiliza-tion rat model. Bone 2011;48:197-201.
7. Drake MT, Srinivasan B, Mödder UI, et al. Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women. J Clin Endocrinol Metab 2010;95:5056-5062.
8. Mödder UI, Clowes JA, Hoey K, et al. Regulation of circulating sclerostin levels by sex steroids in women and in men. J Bone Miner Res 2011;26:27-34.
9. Cornish J, Callon K, King A, Edgar S, Reid IR. The effect of leukemia inhibitory factor on bone in vivo. Endocrinology 1993;132:1359-1366.
10. Vincent C, Findlay DM, Welldon KJ, et al. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-acti-vated protein kinase (MAPK)-dependent expression of sclerostin in human osteo-blasts. J Bone Miner Res 2009;24:1434-1449.
11. Walker EC, McGregor NE, Poulton IJ, et al. Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodeling. J Bone Miner Res 2008;23:2025-2032.
12. Walker EC, McGregor NE, Poulton IJ, et al. Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice. J Clin Invest 2010;120:582-592.
13. Lin C, Jiang X, Dai Z, et al. Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling. J Bone Miner Res 2009;24:1651-1661.
14. Oryan A, Monazzah S, Bigham-Sadegh A. Bone injury and fracture healing biology. Biomed Environ Sci 2015;28:57-71.
15. Kwong FN, Harris MB. Recent developments in the biology of fracture repair. J Am Acad Orthop Surg 2008;16:619-625.
16. Goldhahn J, Féron JM, Kanis J, et al. Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paper. Calcif Tissue Int 2012;90:343-353.
17. Schindeler A, McDonald MM, Bokko P, Little DG. Bone remodeling during fracture repair: the cellular picture. Semin Cell Dev Biol 2008;19:459-466.
18. Khan SN, Cammisa FP Jr, Sandhu HS, et al. The biology of bone grafting. J Am Acad Orthop Surg 2005;13:77-86.
19. McKee MD. Management of segmental bony defects: the role of osteoconductive orthobiologics. J Am Acad Orthop Surg 2006;14 (10 Spec No.):S163-S167.
20. Roberts TT, Rosenbaum AJ. Bone grafts, bone substitutes and orthobiologics: the bridge between basic science and clinical advancements in fracture healing. Organo-genesis 2012;8:114-124.
21. Urist MR. Bone: formation by autoinduction. Science 1965;150:893-899.
22. Fillingham YA, Lenart BA, Gitelis S. Function after injection of benign bone lesions with a bioceramic. Clin Orthop Relat Res 2012;470:2014-2020.
23. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma 1989;3:192-195.
24. Finkemeier CG. Bone-grafting and bone-graft substitutes. J Bone Joint Surg [Am] 2002;84-A:454-464.
25. De Long WG Jr, Einhorn TA, Koval K, et al. Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis. J Bone Joint Surg [Am] 2007;89-A:649-658.
26. Kurien T, Pearson RG, Scammell BE. Bone graft substitutes currently available in orthopaedic practice: the evidence for their use. Bone Joint J 2013;95-B:583-597.
27. Healy KE, Guldberg RE. Bone tissue engineering. J Musculoskelet Neuronal Interact 2007;7:328-330.
28. Aulakh TS, Jayasekera N, Kuiper JH, Richardson JB. Long-term clinical outcomes following the use of synthetic hydroxyapatite and bone graft in impaction in revision hip arthroplasty. Biomaterials 2009;30:1732-1738.
29. McNamara I, Deshpande S, Porteous M. Impaction grafting of the acetabulum with a mixture of frozen, ground irradiated bone graft and porous synthetic bone substitute (Apapore 60). J Bone Joint Surg [Br] 2010;92-B:617-623.
30. Kloen P, Di Paola M, Borens O, et al. BMP signaling components are expressed in human fracture callus. Bone 2003;33:362-371.
31. Even J, Eskander M, Kang J. Bone morphogenetic protein in spine surgery: current and future uses. J Am Acad Orthop Surg 2012;20:547-552.
32. Khan SN, Fraser JF, Sandhu HS, et al. Use of osteopromotive growth factors, demineralized bone matrix, and ceramics to enhance spinal fusion. J Am Acad Orthop Surg 2005;13:129-137.
33. Carreira AC, Alves GG, Zambuzzi WF, Sogayar MC, Granjeiro JM. Bone Mor-phogenetic Proteins: structure, biological function and therapeutic applications. Arch Biochem Biophys 2014;561:64-73.
34. Rosset P, Deschaseaux F, Layrolle P. Cell therapy for bone repair. Orthop Trauma-tol Surg Res 2014;100 (suppl):S107-S112.
35. Fröhlich M, Grayson WL, Wan LQ, et al. Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance. Curr Stem Cell Res Ther 2008;3:254-264.